IM Cannabis (US:IMCC) Prnewswire·2024-08-06 12:30Core Insights - IM Cannabis Corp. will report its operational and financial results for Q2 2024 on August 14, 2024, before market opens [1] - A Zoom web conference will be held on the same day at 9:00 am ET to discuss the results, followed by a Q&A session for investors [2] Company Overview - IM Cannabis Corp. is a leading international cannabis company focused on providing premium cannabis products to medical patients in Israel and Germany, which are significant medical cannabis markets [3] - The company aims for sustainable and profitable growth by leveraging a data-driven approach and a globally sourced product supply chain [3] - IM Cannabis is committed to responsible growth and compliance with strict regulatory environments to enhance its commercial and brand power [3] Operations - In Israel, the company operates through Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, utilizing proprietary data and patient insights [4] - The company also runs medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel to ensure safe delivery and quality control of its products [4] - In Germany, IM Cannabis operates through Adjupharm GmbH, distributing cannabis to pharmacies for medical cannabis patients [4]